ArticleCardiovascular diabetology2017

Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study.

Anna Solini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.